Palisade Bio Granted European Patent Titled ‘COMPOSITIONS FOR THE TREATMENT OF AUTODIGESTION’
https://t.co/AueY3cBqG2?amp=1
52 Biggest Movers From Yesterday
Gainers
Paltalk, Inc. (NASDAQ: PALT) shares jumped 60.1% to close at $8.39 on Wednesday.
The Daily Biotech Pulse: Restricted Authorization For Pfizer’s COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 22)
3 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
4 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Palisade Bio Q2 EPS $(4.10) Down From $(0.67) YoY
Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(4.10) per share. This is a 511.94 percent decrease over losses of $(0.67) per share from the same period last year.
Palisade Bio Share Spike Higher; Co Announces $5.2M Investment By Yuma Regional Medical Center
Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade Bio" or the "Company"), a late‐stage biopharma company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announces a new